Published By: Syndicate Market Research
Pyrimethamine Treatment Market – Global Industry
Perspective, Comprehensive Analysis and Forecast, 2014 2020
Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach,
Florida 33442, USA
Tel: +1-386-310-3803
Toll Free: 1-855-465-4651
sales@SyndicateMarketResearch.com
http://www.syndicatemarketresearch.com/
Pyrimethamine Treatment Market
Pyrimethamine is an antiparasitic compound and used to treat serious parasite infection of the
body, brain. It can be also utilized to prevent toxoplasmosis infection in individuals with HIV
infection. Pyrimethamine possesses some tissue schizonticidal action against malaria parasites
of humans. The combination of pyrimethamine with sulfadoxine is used prevent certain types of
malaria. Pyrimethamine belongs to a category of drugs known as antiparasitics. However, the
Centers for Disease Control and Prevention (CDC), no longer recommends consumption of
pyrimethamine alone to prevent or treat malaria.
Increasing prevalence of toxoplasmosis coupled with high investment in R&D for toxoplasmosis
is expected to propel the market growth in the years to come. Rising incidence of protozoan
disease such as malaria in Asia Pacific region could further surge the market growth. Moreover,
government initiatives and regulations expected to drive the market for pyrimethamine
treatment market in the region over the forecast period. However, several side effects of higher
doses of pyrimethamine such as abdominal cramps, nausea, vomiting, dry mouth, weight loss,
and diarrhea may hamper market growth during the forecast period.
sales@SyndicateMarketResearch.com
Pyrimethamine Treatment Market
The study provides a decisive view on the pyrimethamine treatment market by segmenting the
market based on drug and geography. Based on drug, the pyrimethamine treatment market has
been segmented into two drugs such as Daraprim and Fansidar. The Daraprim segment
accounted for...